On the other hand, high HIF-1α expression in the tumor stroma was significantly more frequent in patients with non-endometrioid tumor subtype, high grade tumors, lymph node metastasis, high FIGO stage and in tumors with loss of hormone receptors (Table 2, Figure 1C). Here, HIF1A is linked to metastatic malignant neoplasm in the lymph nodes.